DSIP
Delta Sleep-Inducing Peptide. A brain-origin peptide aimed at sleep architecture. Limited human data, mixed user reports.
DSIP (Delta Sleep-Inducing Peptide) is a sleep-architecture peptide. Some users notice deeper sleep within nights, others nothing. Limited human data. Sub-q dose taken pre-bed.
Not FDA approved.
Not formally categorized in the FDA bulks lists.
Not prescribed in conventional medicine.
Who it's for
- →Users with disrupted deep-sleep architecture
- →People who want a non-melatonin, non-benzo sleep tool
- →Stack add-on for recovery cycles
What to expect
- Week 1
Effect within 1-3 nights for responders. Non-responders won't notice.
- Week 4
Sleep tracker data usually shows the change if it's real. If working, hold.
- Week 8
If still helping, cycle off briefly to confirm it's the peptide and not just routine changes.
Dosing protocol
100-300 mcg sub-q, 30-60 min pre-bed.
Stacks well with
Side effects
When NOT to use
- ⚠Pregnancy / nursing — no data
Common mistakes
- • Expecting it to work like a sedative (it doesn't sedate, it shifts architecture)
- • Trying once and giving up — give it a week
- • Stacking with too many sleep aids and crediting DSIP for everything
Educational only. User-specific dosing is between you and a qualified provider.